Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fate Therapeutics (NQ: FATE )

71.60 USD +5.09 (+7.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,060,422
Open 67.14
Bid (Size) 68.50 (1)
Ask (Size) 71.35 (5)
Prev. Close 66.51
Today's Range 65.60 - 72.29
52wk Range 35.40 - 121.16
Shares Outstanding 95,184,547
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Fate Therapeutics Announces Publication of FT538 Preclinical Data Demonstrating Enhanced Serial Killing and Functional Persistence without Cytokine Support
Peer-Reviewed Cell Stem Cell Publication Highlights Shared Metabolic, Transcriptional, and Functional Features of FT538 and Adaptive NK Cells 
From GlobeNewswire News Releases
Fate Therapeutics to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases

Performance

YTD
-20.16%
-20.16%
1 Month
-16.38%
-16.38%
3 Month
-12.58%
-12.58%
6 Month
-22.11%
-22.11%
1 Year
+82.42%
+82.42%

More News

Read More
Fate Therapeutics Announces Positive Interim Clinical Data from its FT596 and FT516 Off-the-shelf, iPSC-derived NK Cell Programs for B-cell Lymphoma
From GlobeNewswire News Releases
Peek Under The Hood: FNX Has 12% Upside
Tags ETFs
From ETF Channel
Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain
Tags FATE ARKG Market News
From Motley Fool
Fate Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating
From Investor's Business Daily
Fate Therapeutics Sees Relative Strength Rating Climb To 78
From Investor's Business Daily
12 Health Care Stocks Moving In Friday's Intraday Session
Tags RGC Movers BZI/TFM
From Benzinga
Stocks To Watch: Fate Therapeutics Sees Relative Strength Rating Jump To 80
From Investor's Business Daily
Mid-Morning Market Update: Markets Rise; Deere Beats Q3 Expectations
Tags FLGC Earnings Mid/Morning Market Update
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags SLRX AZRX Movers
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.